The recent GTG-1002 campaign is not just another breach - it is a watershed moment in offensive cyber operations. For decades ...
TipRanks on MSN
Lumen price target raised to $8 from $4.25 at RBC Capital
RBC Capital raised the firm’s price target on Lumen (LUMN) to $8 from $4.25 and keeps a Sector Perform rating on the shares. The company’s Q3 ...
NetApp celebrates partner excellence in addressing customers’ evolving needs and enabling Australia and New Zealand’s digital ...
Zacks Investment Research on MSN
Here's Why Align Technology (ALGN) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
Arpeggio Biosciences Inc., a Boulder-based company that works in the development of pharmaceuticals, has raised about two-thirds of what it expects to collect in its latest investment offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback